Key priority area
Improve access to clinical trials in pancreatic cancer, including for people with metastatic disease
Strategies and activities
Each key priority area has supporting strategies and associated activities for implementation in the short, medium or long term that have been identified to achieve the priority. Click on the strategies below to explore these in more detail.
Strategy
Promote participation in clinical trials for pancreatic cancer
Activities
Short term
Promote patient and clinician awareness on the benefits of participation in clinical trials for, people with metastatic disease
Identify barriers to patient participation in a clinical trial
Medium term
Design and implement standardised approach for routine access to clinical trials, leveraging technology and innovation